184 related articles for article (PubMed ID: 22261065)
21. Kinetics processivity and the direction of motion of Ncd.
Pechatnikova E; Taylor EW
Biophys J; 1999 Aug; 77(2):1003-16. PubMed ID: 10423445
[TBL] [Abstract][Full Text] [Related]
22. Dimeric Eg5 maintains processivity through alternating-site catalysis with rate-limiting ATP hydrolysis.
Krzysiak TC; Gilbert SP
J Biol Chem; 2006 Dec; 281(51):39444-54. PubMed ID: 17062577
[TBL] [Abstract][Full Text] [Related]
23. The structural switch of nucleotide-free kinesin.
Cao L; Cantos-Fernandes S; Gigant B
Sci Rep; 2017 Feb; 7():42558. PubMed ID: 28195215
[TBL] [Abstract][Full Text] [Related]
24. Pathway of ATP hydrolysis by monomeric kinesin Eg5.
Cochran JC; Krzysiak TC; Gilbert SP
Biochemistry; 2006 Oct; 45(40):12334-44. PubMed ID: 17014086
[TBL] [Abstract][Full Text] [Related]
25. S-trityl-L-cysteine is a reversible, tight binding inhibitor of the human kinesin Eg5 that specifically blocks mitotic progression.
Skoufias DA; DeBonis S; Saoudi Y; Lebeau L; Crevel I; Cross R; Wade RH; Hackney D; Kozielski F
J Biol Chem; 2006 Jun; 281(26):17559-69. PubMed ID: 16507573
[TBL] [Abstract][Full Text] [Related]
26. Coupled chemical and mechanical reaction steps in a processive Neurospora kinesin.
Crevel I; Carter N; Schliwa M; Cross R
EMBO J; 1999 Nov; 18(21):5863-72. PubMed ID: 10545098
[TBL] [Abstract][Full Text] [Related]
27. Closing of the nucleotide pocket of kinesin-family motors upon binding to microtubules.
Naber N; Minehardt TJ; Rice S; Chen X; Grammer J; Matuska M; Vale RD; Kollman PA; Car R; Yount RG; Cooke R; Pate E
Science; 2003 May; 300(5620):798-801. PubMed ID: 12730601
[TBL] [Abstract][Full Text] [Related]
28. ADP release is the rate-limiting step of the MT activated ATPase of non-claret disjunctional and kinesin.
Lockhart A; Cross RA; McKillop DF
FEBS Lett; 1995 Jul; 368(3):531-5. PubMed ID: 7635215
[TBL] [Abstract][Full Text] [Related]
29. Kinetic evidence for low chemical processivity in ncd and Eg5.
Crevel IM; Lockhart A; Cross RA
J Mol Biol; 1997 Oct; 273(1):160-70. PubMed ID: 9367754
[TBL] [Abstract][Full Text] [Related]
30. "Snapshots" of ispinesib-induced conformational changes in the mitotic kinesin Eg5.
Kaan HY; Major J; Tkocz K; Kozielski F; Rosenfeld SS
J Biol Chem; 2013 Jun; 288(25):18588-98. PubMed ID: 23658017
[TBL] [Abstract][Full Text] [Related]
31. A kinesin motor in a force-producing conformation.
Heuston E; Bronner CE; Kull FJ; Endow SA
BMC Struct Biol; 2010 Jul; 10():19. PubMed ID: 20602775
[TBL] [Abstract][Full Text] [Related]
32. Crystal structure of the mitotic spindle kinesin Eg5 reveals a novel conformation of the neck-linker.
Turner J; Anderson R; Guo J; Beraud C; Fletterick R; Sakowicz R
J Biol Chem; 2001 Jul; 276(27):25496-502. PubMed ID: 11328809
[TBL] [Abstract][Full Text] [Related]
33. The nucleotide cycle of spastin correlates with its microtubule-binding properties.
Wen M; Wang C
FEBS J; 2013 Aug; 280(16):3868-77. PubMed ID: 23745751
[TBL] [Abstract][Full Text] [Related]
34. Identification of the protein binding region of S-trityl-L-cysteine, a new potent inhibitor of the mitotic kinesin Eg5.
Brier S; Lemaire D; Debonis S; Forest E; Kozielski F
Biochemistry; 2004 Oct; 43(41):13072-82. PubMed ID: 15476401
[TBL] [Abstract][Full Text] [Related]
35. Docking and rolling, a model of how the mitotic motor Eg5 works.
Rosenfeld SS; Xing J; Jefferson GM; King PH
J Biol Chem; 2005 Oct; 280(42):35684-95. PubMed ID: 16115880
[TBL] [Abstract][Full Text] [Related]
36. Interaction of mant-adenosine nucleotides and magnesium with kinesin.
Cheng JQ; Jiang W; Hackney DD
Biochemistry; 1998 Apr; 37(15):5288-95. PubMed ID: 9548760
[TBL] [Abstract][Full Text] [Related]
37. Comprehensive structural model of the mechanochemical cycle of a mitotic motor highlights molecular adaptations in the kinesin family.
Goulet A; Major J; Jun Y; Gross SP; Rosenfeld SS; Moores CA
Proc Natl Acad Sci U S A; 2014 Feb; 111(5):1837-42. PubMed ID: 24449904
[TBL] [Abstract][Full Text] [Related]
38. Significant decrease of ADP release rate underlies the potent activity of dimethylenastron to inhibit mitotic kinesin Eg5 and cancer cell proliferation.
Sun L; Sun X; Xie S; Yu H; Zhong D
Biochem Biophys Res Commun; 2014 May; 447(3):465-70. PubMed ID: 24732354
[TBL] [Abstract][Full Text] [Related]
39. Individual dimers of the mitotic kinesin motor Eg5 step processively and support substantial loads in vitro.
Valentine MT; Fordyce PM; Krzysiak TC; Gilbert SP; Block SM
Nat Cell Biol; 2006 May; 8(5):470-6. PubMed ID: 16604065
[TBL] [Abstract][Full Text] [Related]
40. Microtubule cross-linking triggers the directional motility of kinesin-5.
Kapitein LC; Kwok BH; Weinger JS; Schmidt CF; Kapoor TM; Peterman EJ
J Cell Biol; 2008 Aug; 182(3):421-8. PubMed ID: 18678707
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
